Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection
Rapid Communications in Mass Spectrometry · 2026-01 · 40 (1)
DOI: 10.1002/rcm.10147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 30.09.2025. Verfasst von Shino Ann Koshy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Rationale
Effective pain management remains a persistent challenge, with opioids limited by tolerance, dependence, respiratory depression, and misuse. This has created demand for safer, nonaddictive alternatives. Suzetrigine (VX‐548, Journavx) is a novel analgesic with promising efficacy, but its potential misuse in competitive racing requires investigation. Limited information is available on its metabolism and detection, emphasizing the need for metabolic characterization to aid antidoping strategies.
Methods
In vitro metabolism of suzetrigine was evaluated using equine liver microsomes and homogenized camel liver. Metabolic profiling was carried out using high‐resolution LC–HRMS. Fragmentation analysis was performed to assign metabolite structures and characterize biotransformation pathways.
Results
Seven phase I metabolites (M1–M7) were identified, primarily via hydroxylation, methylation, demethylation, detrifluoromethylation, and cleavage of the pyridine‐2‐carboxamide moiety. One phase II metabolite (M8), formed by sulfation of the demethylated metabolite M5, was detected exclusively with camel liver. Metabolite structures were tentatively assigned based on mass fragmentation data, which showed characteristic neutral losses and diagnostic ions. Comparative analysis revealed that both species shared common phase I pathways, but camel liver demonstrated additional conjugation capacity.
Conclusion
This study provides the first comprehensive characterization of suzetrigine metabolism in equine and camel liver systems. The results underscore metabolic variations, propose a biotransformation pathway, and offer crucial insights to support the development of antidoping detection strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE.
ORCID-Profile: Abdul Khader Karakka Kal
Zitieren
APA
Koshy, S. A., Ajeebsanu, M. M., Karakka Kal, A. K., Subhahar, M. B., Karatt, T. K., & Philip, M. (2026). Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection. Rapid Communications in Mass Spectrometry, 40(1). https://doi.org/10.1002/rcm.10147
Vancouver
Koshy SA, Ajeebsanu MM, Karakka Kal AK, Subhahar MB, Karatt TK, Philip M. Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection. Rapid Communications in Mass Spectrometry. 2026;40(1). doi:10.1002/rcm.10147
BibTeX
@article{Koshy2026,
author = {Koshy, Shino Ann and Ajeebsanu, Meleparappil Muhammed and Karakka Kal, Abdul Khader and Subhahar, Michael Benedict and Karatt, Tajudheen K and Philip, Moses},
title = {Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection},
journal = {Rapid Communications in Mass Spectrometry},
year = {2026},
volume = {40},
number = {1},
doi = {10.1002/rcm.10147}
}
EUVIMED